ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CDIO Cardio Diagnostics Holdings Inc

0.7297
0.0147 (2.06%)
After Hours
Last Updated: 17:29:36
Delayed by 15 minutes

Period:

Draw Mode:

Volume 191,095
Bid Price 0.6803
Ask Price 0.73
News -
Day High 0.7299

Low
0.171

52 Week Range

High
3.56

Day Low 0.6833
Company Name Stock Ticker Symbol Market Type
Cardio Diagnostics Holdings Inc CDIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0147 2.06% 0.7297 17:29:36
Open Price Low Price High Price Close Price Prev Close
0.715 0.6833 0.7299 0.70 0.715
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
598 191,095 $ 0.7006421 $ 133,889 - 0.171 - 3.56
Last Trade Time Type Quantity Stock Price Currency
18:34:54 20 $ 0.6804 USD

Cardio Diagnostics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.36M 20.52M - 17k -8.38M -0.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cardio Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDIO Message Board. Create One! See More Posts on CDIO Message Board See More Message Board Posts

Historical CDIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.87250.890.67230.7281015338,658-0.1428-16.37%
1 Month0.751.120.62120.85725651,064,566-0.0203-2.71%
3 Months1.621.820.62121.02611,885-0.8903-54.96%
6 Months2.123.560.62122.041,388,981-1.39-65.58%
1 Year1.523.560.1711.313,964,307-0.7903-51.99%
3 Years4.258.49990.1712.043,188,113-3.52-82.83%
5 Years4.258.49990.1712.043,188,113-3.52-82.83%

Cardio Diagnostics Description

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease.